CASE REPORT article

Front. Pediatr.

Sec. Genetics of Common and Rare Diseases

Volume 13 - 2025 | doi: 10.3389/fped.2025.1588675

This article is part of the Research TopicEndothelium, Innate Immunity and Coagulation in Hematological DisordersView all 12 articles

A Chinese Family with MYH9-RD Caused by MYH9 p.E1841K Mutation Exhibiting Widespread May-Hegglin Inclusions

Provisionally accepted
Xiaoqiang  LianXiaoqiang Lian1Haixia  LiHaixia Li2Jihong  HaoJihong Hao3Haixin  LiHaixin Li1Ling  XuLing Xu1Shuxia  ZhangShuxia Zhang1Li  CaoLi Cao1Ruimin  LiRuimin Li1*
  • 1Clinical Laboratory, HanDan Central Hospital, Handan, Hebei Province, China
  • 2Anesthesiology, HanDan Central Hospital, Handan, Hebei Province, China
  • 3Clinical Laboratory, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China

The final, formatted version of the article will be published soon.

MYH9-related disease (MYH9-RD) is a rare autosomal dominant genetic syndrome characterized by congenital thrombocytopenia associated with the risk of developing progressive nephropathy, sensorineural deafness, and presenile cataract. This disorder is often misdiagnosed as immune thrombocytopenic purpura (ITP), particularly in patients presenting with isolated thrombocytopenia. Here, we report the case of a 10-year-old girl initially diagnosed with ITP due to isolated thrombocytopenia and intermittent epistaxis. Further evaluation revealed giant platelets on peripheral blood and bone marrow smears, along with blue inclusions in neutrophils, eosinophils, and monocytes. Family history indicated thrombocytopenia in her mother and maternal grandmother, with her mother also having mild hearing impairment and her grandmother having died of renal failure, both of which are common non-hematological manifestations of MYH9-RD. Genetic testing confirmed the presence of an MYH9 p.E1841K mutation inherited from her mother, leading to a definitive diagnosis of MYH9-RD. This case underscores the importance of considering MYH9-RD in the differential diagnosis of unexplained thrombocytopenia, particularly in the presence of characteristic cytological findings and relevant family history. It also highlights the phenotypic consistency within affected families, emphasizing the necessity of ongoing monitoring and follow-up for relatives carrying the mutation.

Keywords: Inherited thrombocytopenia, MYH9 related disease, Leukocyte inclusion, Giant platelets, Non-muscle myosin heavy chain II-A

Received: 06 Mar 2025; Accepted: 14 Jul 2025.

Copyright: © 2025 Lian, Li, Hao, Li, Xu, Zhang, Cao and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ruimin Li, Clinical Laboratory, HanDan Central Hospital, Handan, Hebei Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.